US FDA grants fast track designation to NKGen Biotech’s natural killer cell therapy, troculeucel to treat moderate Alzheimer’s disease: Santa Ana, California Saturday, Februar ...

Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

SHANGHAI and NANJING, China and SAN JOSE, Calif., Feb. 14, 2025 /PRNewswire/ -- IASO Biotherapeutics ('IASO Bio'), a biopharmaceutical company focused on the discovery, development, manufacturing, and ...

Scientists have unlocked the mysteries of the 'extracellular matrix' which holds tumours together and the discovery could ...

Scientists have discovered a new way to predict which cancer tumours will become aggressive before they spread – paving the ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

Delivering drugs to specific, hard-to-reach areas in the human body remains a challenge in drug development. Typically, drug molecules administered via pills or injections circulate randomly through ...

This contract involves Da An Biotherapeutics supplying antibodies that LigaChem Biosciences will develop into ADC new drugs. The next-generation cancer treatment core technology, ADC, accurately ...

Astellas has invested heavily in novel technologies that are not necessarily the most successful or popular in the industry.

Kuick Research Report Highlights Ongoing Developments In Molecular Switches Application Therapeutic Targets & Drug Delivery ...

Terrain Biosciences launches from stealth today as the world's first RNA design-build company, using advanced AI and its ...